Paclitaxel-induced acute myocardial infarction: a case report and literature review.

Paclitaxel is a chemotherapeutic agent commonly used for ovarian, lung, breast carcinoma, and Kaposi's sarcoma. Its common side effects include hypersensitivity reaction, bone marrow suppression, and peripheral neuropathy. However, a rare and life-threatening side effect is paclitaxel-induced myocardial infarction. A 71-year-old man with type 2 diabetes mellitus, hypertension, heavy smoking history, previous coronary artery disease with percutaneous coronary intervention (PCI) in left anterior descending artery (LAD), and non-small lung cancer presented with non-ST elevation myocardial infarction during infusion of paclitaxel infusion. Coronary angiogram showed de novo three vessel disease with 70% stenosis in ostial to distal left main artery (LM) and 80% in-stent re-stenosis in proximal to mid left anterior descending artery. Physicians should be keeping this in mind when dealing with patients on paclitaxel, especially if they have previous risk factors for coronary artery disease. © 2024. The Author(s).

Citation

Gi Eun Kim, Ayman R Ibrahim, Duha Shalatouni, Nadin H Abouzeid, Fahmi Othman. Paclitaxel-induced acute myocardial infarction: a case report and literature review. BMC cardiovascular disorders. 2024 Mar 19;24(1):167

Mesh Tags

Substances

PMID: 38504152

search → result